# LACOSAMIDE
> **ANDA220386** · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2026-01-29
## Drug
- **FDA Application Number:** ANDA220386
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LACOSAMIDE
- **Generic name:** LACOSAMIDE ORAL
- **Active ingredients:** LACOSAMIDE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** REGCON HOLDINGS
- **Manufacturer:** Florida Pharmaceutical Products, LLC
- **First approval:** 2026-01-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220386)
---
*MORVS · CC0 1.0*